|
|
Volumn 487, Issue , 2009, Pages 331-341
|
|
Treating respiratory viral diseases with chemically modified, second generation intranasal siRNAs.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
MESSENGER RNA;
SMALL INTERFERING RNA;
VIRUS RNA;
ANIMAL;
ARTICLE;
BAGG ALBINO MOUSE;
BREATHING DISORDER;
DRUG ANTAGONISM;
GENE SILENCING;
GENE THERAPY;
GENETIC TRANSFECTION;
GENETICS;
HELA CELL;
HUMAN;
INTRANASAL DRUG ADMINISTRATION;
ISOLATION AND PURIFICATION;
METABOLISM;
METHODOLOGY;
MOUSE;
RESPIRATORY SYNCYTIAL PNEUMOVIRUS;
VIRUS INFECTION;
ADMINISTRATION, INTRANASAL;
ANIMALS;
ANTIVIRAL AGENTS;
GENE SILENCING;
GENE THERAPY;
HELA CELLS;
HUMANS;
MICE;
MICE, INBRED BALB C;
RESPIRATION DISORDERS;
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;
RESPIRATORY SYNCYTIAL VIRUSES;
RNA, MESSENGER;
RNA, SMALL INTERFERING;
RNA, VIRAL;
TRANSFECTION;
MLCS;
MLOWN;
|
|
EID: 64549090691
PISSN: 10643745
EISSN: None
Source Type: Journal
DOI: 10.1007/978-1-60327-547-7_16 Document Type: Article |
|
Times cited : (12)
|
|
References (0)
|
